Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 6/2009

01-06-2009 | Short Communication

Radiological imaging change in a malignant bowel obstruction patient treated with octreotide

Authors: Takuya Shinjo, Ryogo Kagami

Published in: Supportive Care in Cancer | Issue 6/2009

Login to get access

Abstract

Introduction

Malignant bowel obstruction (MBO) is a complication in advanced cancer patients with abdominal and pelvic malignancy. Recent research has established the efficacy of octreotide for MBO-related symptom relief. The mechanism that octreotide increases water absorption in case of MBO has not been demonstrated except for experimental animal and normal human model.

Case report

We present a 60-year-old man with pancreatic cancer and MBO treated with octreotide. Radiological imaging showed the disappearance of large-volume fluid retention in the small intestine with alleviating vomiting within 2 days. This radiological change might result from the effect of octreotide increasing water absorption in intestine tract.
Literature
1.
Feuer DJ, Broadley KE (2000) Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 2:CD001219PubMed
2.
Guiro FF, Bertolini G, Salas JV (1999) Improvement in the intestinal processes of hydroelectrolytic absorption and secretion in abdominal pathologies of surgical interest treated with SMS 201–995: experimental protocol. Surg Today 29:419–430PubMedCrossRef
3.
Hogenauer C, Aichbichler B, Santa AC, Porter J, Fordtran J (2002) Effect of octreotide on fluid absorption and secretion by the normal human jejunum and ileum in vivo. Aliment Pharmacol Ther 16:769–777PubMedCrossRef
4.
Mercadante S (1995) Diarrhea in terminally ill patients: pathophysiology and treatment. J Pain Symptom Manage 10:298–309PubMedCrossRef
5.
Mercadante S, Casuccio A, Mangione S (2007) Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage 33:217–223PubMedCrossRef
6.
Mercadante S, Ripamonti C, Casuccio A, Zecca E, Groff L (2000) Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 8:188–191PubMedCrossRef
7.
Mystakidou K, Tsilika E, Kalaidopoulou O, Chondros K, Georgaki S, Papadimitriou L (2002) Comparison of octreotide administration vs. conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial. Anticancer Res 22:1187–1192PubMed
8.
Philip J, Depczynski B (1997) The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy. J Pain Symptom Manage 13:104–111PubMedCrossRef
9.
Ripamonti C (2006) Bowel obstruction. In: Textbook of palliative medicine A Hodder Arnold Publication, London, pp 588–600
10.
Ripamonti C, Easson A, Gerdes H (2008) Management of malignant bowel obstruction. Eur J Cancer 44:1105–1115PubMedCrossRef
11.
Ripamonti C, Mercadante S (2004) Pathophysiology and management of malignant bowel obstruction. In: Oxford textbook of palliative medicine 3rd ed. Oxford University Press, New York, pp 496–506
12.
Ripamonti C, Mercadante S, Groff L, Zecca E, De Conno F, Casuccio A (2000) Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective, randomized trial. J Pain Symptom Manage 19:23–34PubMedCrossRef
13.
Sykes N (2004) Constipation and diarrhoea In: Oxford textbook of palliative medicine 3rd ed. Oxford University Press, New York, pp 483–496
Metadata
Title
Radiological imaging change in a malignant bowel obstruction patient treated with octreotide
Authors
Takuya Shinjo
Ryogo Kagami
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 6/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0608-4

Other articles of this Issue 6/2009

Supportive Care in Cancer 6/2009 Go to the issue

Original Article

Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation

Letter to the Editor

Improve the management of patients with skull bone metastases by means of helical tomotherapy

Short Communication

Futile medication use in terminally ill cancer patients

Supportive Care International

Symptom-monitoring behaviors of rural cancer patients and survivors

Original Article

Child and parental adaptation to pediatric stem cell transplantation

Original Article

Long-term effects on cancer survivors’ quality of life of physical training versus physical training combined with cognitive-behavioral therapy: results from a randomized trial
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits